12:00 AM
 | 
Aug 13, 2012
 |  BC Week In Review  |  Company News  |  Deals

Nodality, Pfizer deal

Nodality and Pfizer partnered to use Nodality's Single Cell Network Profiling (SCNP) technology to develop Pfizer's autoimmune compounds, with an initial focus on lupus. The technology...

Read the full 108 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >